Polygenic risk modeling for prediction of epithelial ovarian cancer risk
Eileen Dareng(University of Cambridge), Rita K. Schmutzler(University of Cologne), Elisa V. Bandera(Rutgers, The State University of New Jersey), Jonathan P. Tyrer(University of Cambridge), Marcus Q. Bernardini(University Health Network), Natalia Bogdanova(Medizinische Hochschule Hannover), Banu Arun(The University of Texas Health Science Center at Houston), Wendy K. Chung(Oregon Health & Science University), Line Bjørge(Haukeland University Hospital), Jenny Chang‐Claude(Universität Hamburg), Kathleen Claes(Statistics Belgium), Michelle R. Jones(Cedars-Sinai Medical Center), Christoph Engel(University Hospital Leipzig), Gerasimos Aravantinos(Hospital Agioi Anargyroi), Daniel Barrowdale(University of Cambridge), Matthias W. Beckmann(Universitätsklinikum Erlangen), Agnieszka Budziłowska(The Maria Sklodowska-Curie National Research Institute of Oncology), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Javier Benı́tez(Spanish National Cancer Research Centre), Daniel R. Barnes(University of Cambridge), Annelie Augustinsson(Lund University), Hayley Cassingham(National Institutes of Health), Amanda Black(St. Elizabeth's Hospital), Yoke-Eng Chiew(The University of Sydney), Xin Yang(National Institutes of Health), Rósa B. Barkardóttir(University of Iceland), Saundra S. Buys(University of Utah), Hoda Anton‐Culver(University of California, Irvine), Bernardo Bonanni(European Institute of Oncology), Fabienne Lesueur(Inserm), Muriel A. Adank(The Netherlands Cancer Institute), Judith Balmañà(Vall d'Hebron Hospital Universitari), Stephen J. Chanock(National Cancer Institute), Kexin Chen(Tianjin Medical University Cancer Institute and Hospital), Simona Agata(Roswell Park Comprehensive Cancer Center), Alicia Beeghly‐Fadiel(University of Helsinki), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Åke Borg(Lund University), Sarah V. Colonna(University of Utah), Marina Bermisheva(Russian Academy of Sciences)
Cited by 73
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k